TILRAY, INC. EMPLOYMENT AGREEMENTEmployment Agreement • June 20th, 2018 • Tilray, Inc. • Medicinal chemicals & botanical products • Washington
THIS EMPLOYMENT AGREEMENT (this “Agreement”) is entered into on May 30, 2018, and effective as of the day of the Company’s initial public offering (the “Effective Date”) entered by and between Tilray, Inc. (the “Company” or “Tilray”, and Mark Castaneda (“Executive”).
CORPORATE SERVICES TERMS AND CONDITIONSCorporate Services Terms and Conditions • June 20th, 2018 • Tilray, Inc. • Medicinal chemicals & botanical products • Washington
These Corporate Services Terms and Conditions (this “Agreement”) govern the provision of certain general administrative and related corporate services by Privateer Holdings, Inc., a Delaware corporation (“Provider”) to the entity named in the accompanying Order Confirmation (“Company”).
CLARIFICATION OF CREDIT FACILITYAGREEMENTClarification of Credit • June 20th, 2018 • Tilray, Inc. • Medicinal chemicals & botanical products
This CLARIFICATION OF CREDIT FACILITY AGREEMENT (this “Agreement”) is by and between Privateer Holdings, Inc., a Delaware corporation (the “Lender”), and Tilray Canada, Ltd. (f/k/a “Lafitte Ventures, Ltd.”), a British Columbia corporation (the “Borrower”).
CREDIT FACILITY AGREEMENTCredit Facility Agreement • June 20th, 2018 • Tilray, Inc. • Medicinal chemicals & botanical products • Washington
This CREDIT FACILITY AGREEMENT (this “Agreement”) is effective as of January 1, 2016 (the “Effective Date”), by and between Privateer Holdings, Inc., a Delaware corporation (the “Lender”), and Lafitte Ventures, Ltd., a British Columbia corporation (the “Borrower”).
CONSTRUCTION FACILITY AGREEMENTConstruction Facility Agreement • June 20th, 2018 • Tilray, Inc. • Medicinal chemicals & botanical products • Washington
This CONSTRUCTION FACILITY AGREEMENT (this “Agreement”) is effective as of November 1, 2017 (the “Effective Date”), by and between Privateer Holdings, Inc., a Delaware corporation (the “Lender”), and Bouchard Ventures, Ltd., a British Columbia corporation (the “Borrower”).
TRADEMARK LICENSE TERMS & CONDITIONSTrademark License Terms • June 20th, 2018 • Tilray, Inc. • Medicinal chemicals & botanical products • Washington
The terms and conditions of this Agreement shall govern the grant by Docklight LLC (“Licensor”) of a limited license to use certain intellectual property rights to the party named in the License Schedule (“Licensee”).
TILRAY, INC. EMPLOYMENT AGREEMENTEmployment Agreement • June 20th, 2018 • Tilray, Inc. • Medicinal chemicals & botanical products • Washington
THIS EMPLOYMENT AGREEMENT (this “Agreement”) is entered on this 30th of May, 2018, by and between Tilray, Inc. (the “Company” or “Tilray”, and Brendan Kennedy (“Executive”).
TILRAY, INC. INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • June 20th, 2018 • Tilray, Inc. • Medicinal chemicals & botanical products • Delaware
THIS INVESTOR RIGHTS AGREEMENT (the “Agreement”) is entered into as of February 5, 2018, by and among TILRAY, INC., a Delaware corporation (the “Company”) and the investors set forth on the signature pages hereto, referred to hereinafter as (together, the “Investors” and each individually as an “Investor”) and those certain holders of the Company’s Common Stock listed on Exhibit A hereto (the “Key Holders”)
